In vitro Antimicrobial Susceptibility Testing of Borrelia burgdorferi: Influence of Test Conditions on Minimal Inhibitory Concentration (MIC) Values
- 30 November 1995
- journal article
- Published by Elsevier in Zentralblatt für Bakteriologie
- Vol. 283 (1) , 49-60
- https://doi.org/10.1016/s0934-8840(11)80890-x
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Comparative in vitro activities of clarithromycin, azithromycin, and erythromycin against Borrelia burgdorferiAntimicrobial Agents and Chemotherapy, 1993
- Efficacy of clarithromycin for treatment of experimental Lyme disease in vivoAntimicrobial Agents and Chemotherapy, 1993
- In vitro activity of vancomycin against the spirochete Borrelia burgdorferiAntimicrobial Agents and Chemotherapy, 1993
- In vitro susceptibilities of Borrelia burgdorferi to five oral cephalosporins and ceftriaxoneAntimicrobial Agents and Chemotherapy, 1992
- Treatment of early lyme diseaseThe American Journal of Medicine, 1992
- Detection of Borrelia burgdorferi in biological samples using the polymerase chain reaction assayResearch in Microbiology, 1991
- In-vitro and in-vivo susceptibility of Borrelia burgdorferi to azithromycinJournal of Antimicrobial Chemotherapy, 1990
- New Chemotherapeutic Approaches in the Treatment of Lyme BorreliosisaAnnals of the New York Academy of Sciences, 1988
- Isolation and characterization of the Lyme disease spirochete from the skin of patients with erythema chronicum migransJournal of the American Academy of Dermatology, 1985
- Borrelia burgdorferi sp. nov.: Etiologic Agent of Lyme DiseaseInternational Journal of Systematic and Evolutionary Microbiology, 1984